Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

NCT00865280 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

143

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated

Conditions

Skin Diseases, Infectious

Interventions

DRUG: PTK 0796
DRUG: linezolid
DRUG: moxifloxacin

Sponsor

Paratek Pharmaceuticals Inc

Collaborators

[object Object]